Randomized trial · people

Larazotide: no gut permeability rise after gluten in celiac patients

Checked against the paper Randomized trialPublished by PepVault

The takeaway

This early trial found single doses of larazotide were well tolerated in celiac patients, with no rise in gut leakiness after gluten in the larazotide group.

Kind
Randomized trial
Studied in
People
Published
2007
Journal
Aliment Pharmacol Ther

What they tested

The team tested whether 12 mg doses of larazotide (AT-1001) were safe and well tolerated in people with celiac disease who were given gluten.

How the study was done

A double-blind, randomized, placebo-controlled safety trial in hospital in-patients with celiac disease, comparing single doses of larazotide with placebo (a dummy treatment) during a gluten challenge. Gut permeability, meaning how leaky the intestinal lining is, was measured with lactulose and mannitol urine tests as an exploratory check of whether the drug worked.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Side effects were no more common with larazotide than with placebo. After the gluten exposure, gut permeability rose 70% in the placebo group, while no rise was seen in the larazotide group. Interferon-gamma, a marker of inflammation, went up in 57% of placebo patients compared with 29% of larazotide patients. Gut symptoms showed up more often in the placebo group (P = 0.018).

What it doesn’t show

This was a small safety study using single doses during a short gluten challenge, so it does not show what happens with longer use. The permeability results were an exploratory measure, not the main goal of the trial.

The paper

Paterson et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther. 2007.

The compound

More studies on Larazotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo